Dr. Primal Kaur, a physician scientist and Vice President of Global Development, Inflammation at Amgen, discusses how her personal experience with severe asthma as a child inspired her career in medicine and her work on treatments for chronic inflammatory diseases. She highlights the development of TEZSPIRE (tezepelumab-ekko), a new medication for severe asthma, and emphasizes the fulfillment found in helping patients lead lives less defined by their illness. Dr. Kaur encourages perseverance to those pursuing careers in science and medicine, noting the significant impact they can make.
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
The Journey from Patient to Scientist: A Q&A with Dr. Primal Kaur
Dr. Primal Kaur, a physician scientist and Vice President of Global Development, Inflammation at Amgen, discusses how her personal experience with severe asthma as a child inspired her career in medicine and her work on treatments for chronic inflammatory diseases. She highlights the development of TEZSPIRE (tezepelumab-ekko), a new medication for severe asthma, and emphasizes the fulfillment found in helping patients lead lives less defined by their illness. Dr. Kaur encourages perseverance to those pursuing careers in science and medicine, noting the significant impact they can make.